Aprea Therapeutics
Price & Volume
Stats
See more52W Range | $2.15-$6.70 |
Market Cap | $11.9M |
Shares Short | 46,312 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | 11% |
Gross Profit (12 Mos) | -$7.7M |
Diluted EPS | -$2.80 |
News
See moreYahoo Finance • 2 days ago
Aprea Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Yahoo Finance • 16 days ago
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)
Yahoo Finance • last year
Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
About
CEO | Dr. Oren Gilad Ph.D. |
Address | 3805 Old Easton Road, Doylestown, PA, United States, 18902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
